Loading market dashboard
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SHEZFHealthcareOTCCN
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2027 | $6.17B | $6.17B - $6.17B | $778.74M | $0.526 | 1 |
| Dec 2026 | $5.84B | $5.84B - $5.84B | $736.10M | $0.487 | 1 |
| Dec 2025 | $5.51B | $5.51B - $5.51B | $694.69M | $0.486 | 1 |
| Dec 2024 | $5.24B | $5.19B - $5.28B | $660.80M | $0.447 | 2 |
| Dec 2023 | $4.95B | $4.95B - $4.95B | $820.61M | -$0.143 | 1 |
| Dec 2022 | $7.19B | $7.19B - $7.19B | $1.19B | $0.574 | 1 |
| Dec 2021 | $6.31B | $6.31B - $6.31B | $1.05B | $0.393 | 1 |
| Dec 2020 | $5.42B | $5.42B - $5.42B | $897.90M | $0.643 | 1 |
| Dec 2019 | $4.69B | $4.69B - $4.69B | $777.82M | $0.85 | 1 |
| Dec 2018 | $4.71B | $4.71B - $4.71B | $779.96M | $0.489 | 1 |
| Dec 2016 | $4.69B | $4.69B - $4.69B | $777.26M | $0.723 | 1 |
| Dec 2015 | $3.75B | $3.75B - $3.75B | $622.06M | $0.524 | 1 |